Loading…

Reply to Masaki Shiota and Akira Yokomizo's Letter to the Editor re: Robert J. van Soest, Ellen S. de Morrée, Charlotte F. Kweldam, et al. Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer. Eur Urol 2015;67:981–5

Saved in:

Bibliographic Details
Published in:	European urology 2016-03, Vol.69 (3), p.e43-e44
Main Authors:	van Soest, Robert J, de Morrée, Ellen S, Kweldam, Charlotte F, Wiemer, Erik A.C, Mathijssen, Ron H.J, de Wit, Ronald, van Weerden, Wytske M
Format:	Article
Language:	English
Subjects:	Animals Drug Resistance, Neoplasm Humans Male Phenylthiohydantoin - analogs & derivatives Prostatic Neoplasms, Castration-Resistant - drug therapy Receptors, Androgen - metabolism Taxoids - therapeutic use Urology
Citations:	Items that this one cites
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!